Multicenter Series Defines Post CAR T Enterocolitis Risk

Company Multicenter academic consortium (Nature Medicine) Event Type Peer-reviewed multicenter retrospective series Modality BCMA CAR T (predominantly cilta-cel) Asset Ciltacabtagene autoleucel Target BCMA Disease Area Multiple myeloma; immune effector cell-associated enterocolitis Summary A Nature Medicine study published online November 19 characterized immune effector cell-associated enterocolitis…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *